Characterization of human IRS-1 Phosphorylation at S348, T495, and S1005
Characterization of human IRS-1 Phosphorylation at S348, T495, and S1005
批准号:
7535489
负责人:
Paul R Langlais
金额:
$5.13万
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-09-13 至 2009-09-12
关键词:
ConditionDiseaseGoalsHealth Care CostsHumanIndividualInsulinInsulin ReceptorInsulin ResistanceKnowledgeLaboratoriesMass Spectrum AnalysisMediatingMetabolic syndromeMissionModalityMolecularMolecular TargetMolecular WeightMuscleNon-Insulin-Dependent Diabetes MellitusObesityPathogenesisPatternPhosphorylationPhosphorylation SitePhosphotransferasesPreventionProteinsPublic HealthPurposeRegulationResearchSerineSerine/Threonine PhosphorylationSignaling ProteinSiteSkeletal MuscleTechniquesTestingThreonineThreonine Phosphorylation SiteTissuesTyrosineTyrosine Phosphorylationbasal insulinbasediabetichuman FRAP1 proteinhuman subjectin vivoinsightinsulin receptor substrate 1 proteinprotein functionresearch studyvolunteer
中文摘要
描述(申请人提供):我们实验室的研究重点是人类骨骼肌中胰岛素抵抗的机制。具体地说,我们询问信号蛋白IRS-1的丝氨酸/苏氨酸磷酸化如何调节该蛋白的功能,这是肌肉中胰岛素作用的关键。利用灵敏的质谱学技术,我们鉴定了从人股外侧肌分离的IRS-1的22个丝氨酸/苏氨酸磷酸化位点。我们量化了胰岛素对其中15个残基的体内磷酸化的影响。在这15个位点中,4个残基Ser348、Thr446、Thr495和Ser1005的磷酸化在胰岛素治疗后降低。这项建议的目的是为朗莱博士提供支持,以确定在肥胖和2型糖尿病患者中,与瘦的健康对照组相比,人类IRS-1中胰岛素控制的模式和水平以及人类IRS-1中Ser348、Thr446、Thr495和Ser1005的磷酸化是否被解除调控。这项建议的第二个目的是确定负责它们磷酸化的激酶(S),mTOR是主要的候选激酶。这些实验将提供一个概念性的框架,将我们实验室关于在活体中调节人类肌肉中这些位置的磷酸化的其他结果放在其中。因此,朗莱斯博士的实验将与实验室的更大使命交织在一起。胰岛素抵抗的分子机制的定义将提供有关2型糖尿病发病机制的知识,并有可能为治疗方式提供分子靶点。
与公共卫生相关:了解胰岛素如何在其靶组织(如骨骼肌)中无法正常发挥作用,将有助于深入了解个体如何发展胰岛素抵抗、2型糖尿病、肥胖和代谢综合征。由于这些疾病是一个日益严重的公共卫生问题,加起来约占公共卫生成本的40%,因此必须了解这些疾病的起源、预防和可能的治疗方法。
英文摘要
DESCRIPTION (provided by applicant): Research in our laboratory focuses on the mechanisms of insulin resistance in human skeletal muscle. Specifically, we ask how serine/threonine phosphorylation of the signaling protein IRS-1 modulates the function of this protein, which is a key to insulin action in muscle. Using sensitive mass spectrometry techniques, we identified 22 serine/threonine phosphorylation sites in IRS-1 isolated from human vastus lateralis muscle. We quantified the effect of insulin on the in vivo phosphorylation of 15 of these residues. Of these 15 sites, phosphorylation of 4 residues, Ser348, Thr446, Thr495, and Ser1005, was decreased upon insulin treatment. The purpose of this proposal is to provide support for Dr. Langlais to ascertain whether the insulin controlled pattern and level and of phosphorylation of Ser348, Thr446, Thr495, and Ser1005 in human IRS-1 is deregulated in obese and type 2 diabetic human subjects as compared to lean, healthy controls. The second aim of this proposal is to identify the kinase(s) responsible for their phosphorylation, with mTOR being the principal candidate kinase. These experiments will provide a conceptual framework in which to place into context other results from our laboratory regarding regulation of phosphorylation of these sites in human muscle in vivo. Therefore Dr. Langlais' experiments will interweave with the larger mission of the laboratory. Definition of the molecular mechanisms responsible for insulin resistance will provide knowledge regarding the pathogenesis of type 2 diabetes mellitus and potentially provide molecular targets for treatment modalities.
PUBLIC HEALTH RELEVANCE: Understanding how insulin fails to function properly in its target tissues, such as skeletal muscle, will provide insight into how individuals develop insulin resistance, type 2 diabetes, obesity, and the metabolic syndrome. Since these diseases are a growing public health problem responsible together for about 40% of public health costs, knowledge of the origins prevention and potential treatments for these diseases are imperative.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Characterizing the Role of CLASP2 in Insulin-Stimulated Glucose Transport
-
批准号:8934079
-
项目类别:
-
资助金额:$37.35万
-
财政年份:2014
-
负责人:Paul R Langlais
-
依托单位:
Characterizing the Role of CLASP2 in Insulin-Stimulated Glucose Transport
-
批准号:9341235
-
项目类别:
-
资助金额:$34.54万
-
财政年份:2014
-
负责人:Paul R Langlais
-
依托单位:
Characterizing the Role of CLASP2 in Insulin-Stimulated Glucose Transport
-
批准号:8817983
-
项目类别:
-
资助金额:$37.35万
-
财政年份:2014
-
负责人:Paul R Langlais
-
依托单位:
Characterizing the Role of CLASP2 in Insulin-Stimulated Glucose Transport
-
批准号:9135353
-
项目类别:
-
资助金额:$12.11万
-
财政年份:2014
-
负责人:Paul R Langlais
-
依托单位:
Characterization of human IRS-1 Phosphorylation at S348, T495, and S1005
-
批准号:7405688
-
项目类别:
-
资助金额:$4.96万
-
财政年份:2007
-
负责人:Paul R Langlais
-
依托单位:
国内基金
海外基金
登录
查看更多内容
骨髓基质干细胞移植对AD(Alzheimer disease)小鼠海马及额叶神经细胞死亡干预的实验研究
-
批准号:81301089
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2013
-
负责人:商敬伟
-
依托单位:
新型F-18标记香豆素衍生物PET探针的研制及靶向Alzheimer's Disease 斑块显像研究
-
批准号:81000622
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2010
-
负责人:梁胜
-
依托单位:
阿尔茨海默病(Alzheimer's disease,AD)动物模型构建的分子机理研究
-
批准号:31060293
-
项目类别:地区科学基金项目
-
资助金额:26.0万元
-
批准年份:2010
-
负责人:郭亚芬
-
依托单位:
Batten Disease (BD)神经元退化病理机制的研究
-
批准号:30900802
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2009
-
负责人:吴丹
-
依托单位:
跨膜转运蛋白21(TMP21)对引起阿尔茨海默病(Alzheimer'S Disease)的γ分泌酶的作用研究
-
批准号:30960334
-
项目类别:地区科学基金项目
-
资助金额:22.0万元
-
批准年份:2009
-
负责人:董贵成
-
依托单位: